AdaptVac

Hørsholm, Denmark

AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.

$12.4M raised

Jun 2025

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AdaptVac raised?

AdaptVac has raised $12.4M in total funding. The most recent round was Grant. The last funding was announced in June 2025.

Who are AdaptVac's investors?

AdaptVac's investors include Horizon Europe, Coalition for Epidemic Preparedness Innovations, Innovation Fund Denmark.

Where is AdaptVac headquartered?

AdaptVac is headquartered in Hørsholm, Denmark.

What does AdaptVac do?

AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.

What stage is AdaptVac at?

AdaptVac is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 19, 2025.

MLA

"AdaptVac — Funding & Investors." VCBacked, June 19, 2025, https://www.vcbacked.co/company/adaptvac. Accessed July 3, 2026.

APA

VCBacked. (2025). AdaptVac — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/adaptvac

Wikipedia (cite web)

{{cite web |title=AdaptVac — Funding & Investors |url=https://www.vcbacked.co/company/adaptvac |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 19, 2025.